June, 2024
June 2024
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
Yelak Biru: Kite and Arcellx have announced plans to commence a Phase III clinical trial for myeloma
May 17, 2024, 13:11

Yelak Biru: Kite and Arcellx have announced plans to commence a Phase III clinical trial for myeloma

Yelak Biru, President and CEO of the International Myeloma Foundation, shared on X: .

We need more options in the multiple myeloma toolbox: Kite, a Gilead Company, and Arcellx have announced plans to commence a Phase III clinical trial of anitocabtagene autoleucel (anito-cel), for myeloma.

Anito-cel is a (BCMA CAR) T-cell therapy. Via Clinical Trials Arena.”

Source: Yelak Biru/X